Results 191 to 200 of about 29,631 (205)

Unraveling COVID-19-vaccination-induced bullous pemphigoid: a case report and review of the literature. [PDF]

open access: yesJ Med Case Rep
Chandrasekaran S   +7 more
europepmc   +1 more source

Humoral and functional SARS-CoV-2-specific T-cell responses elicited in chronic lymphocytic leukaemia patients with GEO-CM04S1 a synthetic MVA-vectored COVID-19 vaccine. [PDF]

open access: yesBr J Haematol
Ortega-Francisco S   +24 more
europepmc   +1 more source

Evaluation of vaccine-induced antibody responses against SARS-CoV-2 in multiple myeloma patients from the northeastern region of Mexico. [PDF]

open access: yesHematol Transfus Cell Ther
Salazar-Riojas R   +6 more
europepmc   +1 more source

Acute Kidney Injury Following Vaccine-Induced Thrombotic Microangiopathy. [PDF]

open access: yesEur J Case Rep Intern Med
Aabideen M, Vellanki VS, Tungekar MF.
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Decreased Infectivity Following BNT162b2 Vaccination

SSRN Electronic Journal, 2021
Background: BNT162b2 was shown to be 92% effective in preventing COVID-19. Prioritizing vaccine rollout, and achievement of herd immunity depend on SARS-CoV-2 transmission reduction. The vaccine’s effect on infectivity is thus a critical priority. Methods: In a cohort of all 9650 HCW of a large single tertiary medical center, we calculated the ...
Gili Regev-Yochay   +16 more
openaire   +1 more source

Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents

Pediatrics, 2023
OBJECTIVES We assessed BNT162b2 vaccine effectiveness (VE) against mild to moderate and severe coronavirus disease 2019 (COVID-19) in children and adolescents through the Omicron BA.4/BA.5 period. METHODS Using VISION Network records from April 2021
Nicola P, Klein   +45 more
openaire   +2 more sources

Cellular immune response following homologous and heterologous BNT162b2 booster vaccination after primary immunization with BNT162b2 and CoronaVac respectively

Cellular Immunology
Several vaccines targeting SARS-CoV-2 were developed following the COVID-19 outbreak. However, subsequent studies have indicated that humoral immune responses wane over time, particularly with the emergence of new SARS-CoV-2 variants. There is limited understanding of the resilience of T cell-mediated immunity induced by COVID-19 vaccines.
Mat Jusoh, Siti Asmaa   +10 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy